Skip to main content
OpenTrials

Clinical trial condition

Male Urogenital Diseases

Explore clinical trials studying Male Urogenital Diseases. Study availability and eligibility vary by location and protocol.

20,869 public trials 3,484 recruiting studies
Refine in advanced search Browse all conditions

Male Urogenital Diseases trial results

Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

NCT07000084

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
View all 58 locations
View Trial Details
Recruiting

A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

NCT06245603

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Humanitas Gavezzeni-Bergamo Bergamo, Italy
  • Ospedale Sant'Orsola - Malpighi Bologna, Italy
  • Policlinico Ospedali Riuniti - Foggia Foggia, Italy
  • Istituto Oncologico Veneto IRCCS Padova, Italy
View Trial Details
Recruiting

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT07719361

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +15 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
View Trial Details
Recruiting

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

NCT06960577

Conditions
Cisplatin, Doxorubicin, Female Urogenital Diseases, +14 more
Locations
  • Research Site Chermside, Australia
  • Research Site Elizabeth Vale, Australia
  • Research Site Heidelberg, Australia
  • Research Site Hong Kong, Australia
View all 59 locations
View Trial Details

Related conditions